Updating to take account of recenty developments in stem cell biology.
Increased emphasis on genomic and proteomic techniques in the diagnosis of haematological malignancy.
Use of new imaging techniques including MRI and PET.
Description of advances in treatment of leukaemia and lymphoma and in diagnosis and management of patients with thrombophilia and venous thrombosis.
Development of new antimicrobial agents in management of immunosuppressed patients with infection.
New double page spread on palliative care of patients with blood disorders.
Concise and manageable coverage of the major blood diseases and their treatment.
Does not overload the reader with science, unlike some competing books.
Focus is on the haematology patient and on the practical aspects of the subject.
Makes use of the attractive features of the ICT series - double page spreads, lots of colour illustrations, summary boxes.
By Martin R. Howard, MBChB, MD, FRCP, FRCPath, Consultant Haematologist, York Health Services NHS Trust; Clinical Senior Lecturer, Hull York Medical School, York, UK; and Peter J. Hamilton, MA, BA, BCh, FRCP, FRCPath, Consultant Haematologist, Department of Haematology, Royal Victoria Infirmary, University of Newcastle, Newcastle upon Tyne, UK
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.